AgomAb Therapeutics NV (“Agomab”), a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results